FDA grants priority review status to Gilead’s hepatitis C drug

by Blogburger on July 13, 2013

n”>(Reuters) – Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority…

WN.com – Health News

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: